We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$46.2B
AUM Growth
+$1.83B
(+4.1%)
Cap. Flow
-$543M
Cap. Flow
% of AUM
-1.17%
Top 10 Holdings %
Top 10 Hldgs %
24.86%
Holding
1,809
New
24
Increased
1,140
Reduced
325
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$98M |
| 2 |
Kinder Morgan
KMI
|
+$97.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$96.6M |
| 4 |
UnitedHealth
UNH
|
+$77.5M |
| 5 |
Marriott International
MAR
|
+$58.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$198M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$179M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$162M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$154M |
| 5 |
Bank of America
BAC
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.89% |
| 2 | Healthcare | 18.49% |
| 3 | Financials | 11.85% |
| 4 | Consumer Discretionary | 9.1% |
| 5 | Industrials | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRO
1551
DELISTED
PROS Holdings
PRO
| $643K | ﹤0.01% |
23,470
| – | – |
|
1552
Pathward Financial
CASH
$1.87B
| $641K | ﹤0.01% |
15,460
| – | – |
|
1553
Relay Therapeutics
RLAY
$3.99B
| $641K | ﹤0.01% |
+38,900
| New | +$698K |
|
1554
Haverty Furniture Companies
HVT
$421M
| $640K | ﹤0.01% |
20,050
| – | – |
|
1555
Universal Insurance Holdings
UVE
$1.23B
| $639K | ﹤0.01% |
35,049
+4,250
| +14% | +$62.8K |
|
1556
Digital Turbine
APPS
$1.02B
| $638K | ﹤0.01% |
51,620
-4,478
| -8% | -$60.2K |
|
1557
Vipshop
VIPS
$7.13B
| $638K | ﹤0.01% |
42,000
+11,950
| +40% | +$178K |
|
1558
First Merchants
FRME
$2.74B
| $636K | ﹤0.01% |
19,310
+7,750
| +67% | +$307K |
|
1559
Buckle
BKE
$2.35B
| $636K | ﹤0.01% |
17,807
| – | – |
|
1560
KKR & Co
KKR
$92.2B
| $635K | ﹤0.01% |
12,100
-213,360
| -95% | -$11.4M |
|
1561
NewMarket
NEU
$7.2B
| $635K | ﹤0.01% |
1,741
+750
| +76% | +$260K |
|
1562
Arvinas
ARVN
$529M
| $633K | ﹤0.01% |
23,170
-82,475
| -78% | -$2.61M |
|
|
INN
1563
Summit Hotel Properties
INN
$743M
| $629K | ﹤0.01% |
89,800
+1,950
| +2% | +$14.8K |
|
1564
AZZ Inc
AZZ
$4.41B
| $627K | ﹤0.01% |
15,210
| – | – |
|
|
LYRA
1565
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $626K | ﹤0.01% |
6,045
| – | – |
|
|
AVTA
1566
DELISTED
Avantax, Inc. Common Stock
AVTA
| $625K | ﹤0.01% |
23,758
| – | – |
|
1567
Heartland Express
HTLD
$1.04B
| $625K | ﹤0.01% |
39,274
+9,150
| +30% | +$149K |
|
1568
Enanta Pharmaceuticals
ENTA
$367M
| $625K | ﹤0.01% |
15,450
+250
| +2% | +$11.9K |
|
1569
Ameresco
AMRC
$1.04B
| $622K | ﹤0.01% |
12,640
+1,350
| +12% | +$71.6K |
|
|
VBTX
1570
DELISTED
Veritex Holdings
VBTX
| $621K | ﹤0.01% |
34,030
+1,150
| +3% | +$29.3K |
|
1571
Sylvamo
SLVM
$1.55B
| $621K | ﹤0.01% |
13,420
+950
| +8% | +$45.1K |
|
1572
Pediatrix Medical
MD
$2.21B
| $617K | ﹤0.01% |
41,399
+3,350
| +9% | +$50.7K |
|
1573
Theravance Biopharma
TBPH
$875M
| $616K | ﹤0.01% |
56,730
+9,150
| +19% | +$96.8K |
|
|
NVEE
1574
DELISTED
NV5 Global
NVEE
| $614K | ﹤0.01% |
23,640
+3,400
| +17% | +$102K |
|
1575
Axsome Therapeutics
AXSM
$12.1B
| $614K | ﹤0.01% |
9,950
+550
| +6% | +$36.1K |
|
Similar funds
SCP
Ensign Peak Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Ensign Peak Advisors held 1,809 positions worth $46.2B, up 4.1% from $44.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 3.4%. Ensign Peak Advisors opened 24 new positions and exited 37, leaving the 1,809-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q1 2023 buy was State Street Financial Select Sector SPDR ETF: 1,117,296 shares worth $35.9M.
- Ensign Peak Advisors added most to Eli Lilly in Q1 2023, an estimated $98M increase.
- Ensign Peak Advisors's biggest Q1 2023 reduction was First Republic Bank, cutting an estimated $198M.
- Ensign Peak Advisors fully exited iShares Russell 2000 ETF in Q1 2023, selling an estimated $179M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $46.2B portfolio in Q1 2023.
- Ensign Peak Advisors opened 24 new positions and closed 37 in Q1 2023.
- Ensign Peak Advisors's portfolio value rose 4.1% quarter-over-quarter to $46.2B.
Based on Ensign Peak Advisors's 13F filing for Q1 2023, filed 15 May 2023.